-Firstpost.com It is becoming increasingly difficult to retain respect for Nobel laureate Amartya Sen. He seems to surface in the media every time the UPA government is about to legislate its pet follies, providing intellectual succour to mindless spending and corruption wrapped up in the package of anti-poverty schemes. Yesterday, Sen bobbed up just when the UPA - under siege for every known scam in India - tried to start discussions on...

-The Hindustan Times It now seems increasingly unlikely that Parliament will consider the National Food Security Bill during this budget session. In a land which for centuries suffered devastating famines, where chronic hunger continues to stalk more than 200 million people, and which is home to every third malnourished child on the planet, this would be one more sad betrayal of the country's indigent millions, a reminder of how little they...

-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...

-Bloomberg   In all likelihood, Nandan Nilekani's Aadhaar will lead the world. Exactly where it will lead, we'll find out People who grew up in Britain in the 1960s will remember a television programme that built a cult following: The Prisoner. It was about an oddly luxurious detention camp-a kind of Guantanamo Bay by Four Seasons, spa services and brainwashing included. Even if you wanted to, trying to escape was pointless. A...

-The Indian Express India is no insecure dictatorship junking international obligations for cheap populism. The highest court of the world's largest democracy has made a nuanced distinction between real innovation and marketing gimmickry. Yet, the Swiss pharmaceutical giant Novartis's response to the recent Supreme Court verdict in Novartis vs Union of India has been imperial in tone. The judgment "discourages innovative drug discovery", it claimed. It accused Indian law of lagging...